MONTRÉAL, May 21, 2021 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and MD&A for its second quarter ended March 31, 2021.
Summary
“The March offering and the latest technology roll out puts us in a very enviable position to act as an aggregator in our market.” Said Martin Legault, CEO of Premier Health.
Second Quarter 2021 Results Highlights
March 31, 2021 (3 months) |
March 31, 2020 (3 months) |
March 31, 2021 (6 months) |
March 31, 2020 (6 months) |
|||||||||
Revenues | $17,003,358 | $4,929,790 | $30,363,667 | $8,293,948 | ||||||||
From last period | +245% | +266% | ||||||||||
Gross margin | $4,302,834 | $1,285,980 | $8,106,301 | $2,045,585 | ||||||||
From last period | +235% | +296% | ||||||||||
EBITDA (1) | $1,782,723 | $676,029 | $3,101,442 | $891,574 | ||||||||
From last period | +165% | +249% | ||||||||||
Net Income | $825,189 | ($783,815) | $1,540,833 | ($647,322) | ||||||||
(1) Adjusted EBITDA before non-recurring items
Business Highlights
Financing Highlights
Acquisition of Solutions Nursing
Premier Health completed the acquisition of Solutions Nursing on March 17 for a total consideration of C$2.7M comprised of a $1.9M cash payment at the closing of the transaction and a $0.8M a deferred cash consideration payable over 2 years and subject to the achievement of EBITDA objectives. Solutions Nursing generated revenues of approximately C$4.5M (EBITDA of C$0.6M) in 2020.
About Premier Health
Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services.
Non-GAAP Measures
Earnings before interest, taxes, depreciation and amortization (“EBITDA”), is calculated as the net profit (loss), before non-recurring items such as acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization and depreciation), interest expense, net of interest income and income tax expense.
For Further Information Please Contact:
Mr. Jean-Robert Pronovost
Vice-President, Corporate Development
Premier Health of America Inc.
jrpronovost@premierhealth.ca / 1 800 231 9916
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation’s common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…
- Leading efficient care management for the elderly with unimpeded smartcare https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png SEOUL, South Korea, Nov.…
- Attruby is the first and only approved product with aspecifying near-complete stabilization…
PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…